Chaiqin Chengqi Decoction for Acute Pancreatitis (CQCQDAP trial): study protocol of a randomized, double-blind, placebo-controlled, parallel-group trial

Acute pancreatitis (AP) is the common digestive disease with a potentially high risk of mortality. Traditional Chinese medicinal fomula Chaiqin Chengqi Decoction (CQCQD) has been used for the management of AP in West China Hospital for decades. CQCQD for AP (CQCQDAP) trial tests whether the administration of CQCQD will improve the efficacy of the present comprehensive treatments for AP.

Journal Ref. Unpublished
Intervention Drug - Chaiqin Chengqi Decoction (CQCQD) and placebo CQCQD will be used for the treatment of acute pancreatitis.
Number of sites 1
Countries involved China
Sample size 248
Type of statistical analyses
Risk of bias Overall: Low Risk details
Duration of trial
Primary outcome Duration of respiratory failure
Show Score Ranges


(shows median if more than one score was entered)

Elig. Recr. Setting Org. Int. Flex. Del. Flex. Adherence Follow-Up Prim. Out. Prim. An.
4 5 3 5 5 4 4 5 3